Verisk (VRSK) disagrees with Delaware Chancery Court regarding AccuLynx

Verisk (VRSK) disagrees with Delaware Chancery Court regarding AccuLynx.

Disputes between an acquirer and a Chancery Court over a target have historically centred on whether the buyer is entitled to walk, typically on material adverse effect claims or alleged breaches of interim covenants, and the court's record in such cases has leaned toward enforcing deals rather than releasing buyers. The language of a party 'disagreeing' with the court is characteristic of the post-ruling stage: the operative question is whether the judgment is a preliminary injunction, a specific performance order, or a damages determination, since each carries a different sequence of remedies and appeal options to the Delaware Supreme Court. Acquirers in this posture have often used adverse rulings as leverage to renegotiate price rather than litigate to the end, and targets have typically pressed for specific performance where financing remains committed. Worth watching is any filing indicating appeal or settlement, the status of financing commitments and the drop-dead date mechanics, and whether the counterparty issues its own statement, which has tended to clarify quickly whether the deal survives, re-prices, or breaks with a termination fee.